Neuro-Oncology Reviews
Volume
26 Number 25
10 November 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 25, 10 November
Ghasemi E, Mondanizadeh M, Almasi-Hashiani A, Mahboobi E.
The
significance of miR-124 in the diagnosis and prognosis of glioma:
A systematic review.
PLoS
One. 2024 Nov 1;19(11):e0312250. doi:
10.1371/journal.pone.0312250. PMID:
39485747. Review. ˍ
Liu J, Peng J, Jiang J, Liu Y.
Clinical
immunotherapy in glioma: current concepts, challenges, and future
perspectives.
Front
Immunol. 2024 Nov 1;15:1476436. doi:
10.3389/fimmu.2024.1476436. PMID:
39555054. Review. ˍ
Satish S, Athavale M, Kharkar PS.
Targeted
therapies for Glioblastoma multiforme (GBM): State-of-the-art and
future prospects.
Drug
Dev Res. 2024 Nov 1;85(7):e22261. doi:
10.1002/ddr.22261. PMID:
39485272. Review˰ ˍ
Beylerli O, Gareev I, Ilyasova T, Musaev E, Chekhonin V.
The
Mechanism of Action of Exosomes Derived from Glioblastoma Cells.
Curr
Med Chem. 2024 Nov 4. doi:
10.2174/0109298673344390241017065119. PMID:
39501957. Review˰ ˍ
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A,
Maccari M, Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller
M, Preusser M, Simonelli M, Lombardi G.
PARP
inhibitors in gliomas: Mechanisms of action, current trends and
future perspectives.
Cancer
Treat Rev. 2024 Nov 5;131:102850. doi:
10.1016/j.ctrv.2024.102850. PMID:
39531943. Review. ˍ
Dehghan N, Mousavikia SN, Qasempour Y, Azimian H.
Radiation-induced
senescence in glioblastoma: An overview of the mechanisms and
eradication strategies.
Life
Sci. 2024 Nov 5;359:123218. doi:
10.1016/j.lfs.2024.123218. PMID:
39510171. Review˰ ˍ
Grabenweger R, Völz D, Weck C, Hau P, Paal P, Bumes E.
Spirituality in Professional
Patient-Centered Care for Adults with Primary Brain Tumors: An
Exploratory Scoping Review.
J
Relig Health. 2024 Nov 5. doi:
10.1007/s10943-024-02161-x. PMID:
39500854. Review. ˍ
Ritchey
AK
et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma: Patient
Version.
PDQ
Cancer Inf Summ.
2024
Nov
5. NCBI Bookshelf ID:
NBK65742.
PMID:
26389185.
Review
Imran M, Altamimi ASA, Babu MA, Goyal K, Kaur I, Kumar S, Sharma
N, Kumar MR, Alanazi FJ, Alruwaili AN, Aldhafeeri NA, Ali
H.
Non-coding
RNAs (ncRNAs) as therapeutic targets and biomarkers in
oligodendroglioma.
Pathol
Res Pract. 2024 Nov 6;264:155708. doi:
10.1016/j.prp.2024.155708. PMID:
39531874. Review˰ ˍ
Malone K, LaCasse E, Beug ST.
Cell
death in glioblastoma and the central nervous system.
Cell
Oncol (Dordr). 2024 Nov 6. doi:
10.1007/s13402-024-01007-8. PMID:
39503973. Review. ˍ
Zhou D, Zhu X, Xiao Y.
Advances
in CAR-T therapy for central nervous system tumors.
Biomark
Res. 2024 Nov 6;12(1):132. doi:
10.1186/s40364-024-00679-6. PMID:
39506843. Review. ˍ
Wen PY.
Progress in treatment of
gliomas.
Curr
Opin Neurol. 2024 Nov 7;37(6):655-656. doi:
10.1097/WCO.0000000000001324. PMID:
39498845. Editorial. ˍ
Horsley PJ, Bailey DL, Schembri G, Hsiao E, Drummond J, Back MF.
The
role of amino acid PET in radiotherapy target volume delineation
for adult-type diffuse gliomas: A review of the literature.
Crit
Rev Oncol Hematol. 2024 Nov 8;205:104552. doi:
10.1016/j.critrevonc.2024.104552. PMID:
39521308. Review. ˍ
Richard SA.
The
pivotal role of autophagy in the pathogenesis and therapy of
medulloblastoma.
Future
Oncol. 2024 Nov 8:1-12. doi:
10.1080/14796694.2024.2420629. PMID:
39513232. Review˰ ˍ
Willmann J, Balermpas P, Rimner A,
Appelt AL, Vasquez Osorio EM, Rønde HS, Day
M, Embring A, Gabryś D, Guren MG, Hoskin P, Massaccesi M,
Mayo C, Murray L, Nieder C,
Guckenberger M, Andratschke N.
Ongoing
prospective studies on reirradiation: A systematic review of a
clinical trials database.
Radiother
Oncol.
2024 Nov 10;202:110624. doi:
10.1016/j.radonc.2024.110624. PMID:
39532233. Review. ˍ